Targeting the Aspartic Protease BACE1 for Inhibition in Order to Increase Hypothalamic Leptin Sensitivity and Reverse Obesity

Project Details

StatusFinished
Effective start/end date1/01/1331/12/15

Funding

  • Medical Research Council (MR/K003291/1): £413,705.00